补充维生素D治疗炎症性肠病的研究进展

doi:10.20047/j.issn1673-7210.2023.27.10

Abstract
Figure/Table
References (31)
Related Citation (15)

Download: PDF (673 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Vitamin D not only plays a classic physiological role in maintaining calcium and phosphorus balance, but its immune regulatory role in the pathophysiological process of inflammatory bowel disease is also receiving increasing attention. Previous studies have shown that vitamin D deficiency is very common in patients with inflammatory bowel disease, and vitamin D supplementation plays an important role in reducing excessive inflammatory response and improving the prognosis of patients with inflammatory bowel disease. However, there is currently no unified standard for the dosage form, dosage, and supplementation goals of vitamin D supplementation preparations. This review will review recent researches on inflammatory bowel disease and vitamin D, providing clinical reference for supplementing vitamin D in patients with inflammatory bowel disease.

Key words： Vitamin D Inflammatory bowel disease Ulcerative colitis Crohn’s disease Cholecalciferol

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIAO Mofan1 RAN Yan2 LEI Zhangni1 SHAO Jiayuan1 CHEN Yuling1 LI Yingchao1

Cite this article:

XIAO Mofan1 RAN Yan2 LEI Zhangni1 SHAO Jiayuan1 CHEN Yuling1 LI Yingchao1. Research progress of vitamin D supplementation in the treatment of inflammatory bowel disease[J]. 中国医药导报, 2023, 20(27): 47-50,63.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.27.10 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I27/47

[1] Wu Z，Liu D，Deng F. The role of vitamin D in immune system and inflammatory bowel disease [J]. J Inflamm Res，2022，15：3167-3185.
[2] Jeon S，Shin E. Exploring vitamin D metabolism and function in cancer [J]. Exp Mol Med，2018，50（4）：1-14.
[3] Holick M，Binkley N，Bischoff-Ferrari H，et al. Evaluation，treatment，and prevention of vitamin D deficiency：an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab，2011，96（7）：1911-1930.
[4] Janssen CE，Globig AM，Busse Grawitz A，et al. Seasonal variability of vitamin D status in patients with inflammatory bowel disease-A retrospective cohort study [J]. PLoS One，2019， 14（5）：e0217238.
[5] Gopal-Kothandapani J，Evans L，Walsh J，et al. Effect of vitamin D supplementation on free and total vitamin D：a comparison of Asians and Caucasians [J]. Clin Endocrinol（Oxf），2019，90（1）：222-231.
[6] Khalili H，Huang E，Ananthakrishnan A，et al. Geographical variation and incidence of inflammatory bowel disease among US women [J]. Gut，2012，61（12）：1686-1692.
[7] Ghishan FK，Kiela PR. Vitamins and minerals in inflammatory bowel disease [J]. Gastroenterol Clin North Am，2017，46（4）：797-808.
[8] Burrelli Scotti G，Afferri MT，De Carolis A，et al. Factors affecting vitamin D deficiency in active inflammatory bowel diseases [J]. Dig Liver Dis，2019，51（5）：657-662.
[9] Law A，Dutta U，Kochhar R，et al. Vitamin D deficiency in adult patients with ulcerative colitis：prevalence and relationship with disease severity，extent，and duration [J]. Indian J Gastroenterol，2019，38（1）：6-14.
[10] Rogler G，Singh A，Kavanaugh A，et al. Extraintestinal manifestations of inflammatory bowel disease：current concepts，treatment，and implications for disease management [J]. Gastroenterology，2021，161（4）：1118-1132.
[11] López-Mu?觡oz P，Beltrán B，Sáez-González E，et al. Influence of vitamin D deficiency on inflammatory markers and clinical disease activity in IBD patients [J]. Nutrients，2019， 11（5）：1059.
[12] Ham N，Hwang S，Oh E，et al. Influence of severe vitamin D deficiency on the clinical course of inflammatory bowel disease [J]. Dig Dis Sci，2021，66（2）：587-596.
[13] Shirwaikar Thomas A，Criss Z，Shroyer N，et al. Vitamin D receptor gene single nucleotide polymorphisms and association with vitamin D levels and endoscopic disease activity in inflammatory bowel disease patients：a pilot study [J]. Inflamm Bowel Dis，2021，27（8）：1263-1269.
[14] Aksan A，Tugal D，Hein N，et al. Measuring vitamin D status in chronic inflammatory disorders：how does chronic inflammation affect the reliability of vitamin D metabolites in patients with IBD? [J]. J Clin Med，2020，9（2）：547.
[15] El Amrousy D，El Ashry H，Hodeib H，et al. Vitamin D in children with inflammatory bowel disease：a randomized controlled clinical trial [J]. J Clin Gastroenterol，2021，55（9）：815-820.
[16] Kellermann L，Jensen KB，Bergenheim F，et al. Mucosal vitamin D signaling in inflammatory bowel disease [J]. Autoimmun Rev，2020，19（11）：102672.
[17] Zhang Y，Lu R，Xia Y，et al. Lack of vitamin D receptor leads to hyperfunction of Claudin-2 in intestinal inflammatory responses [J]. Inflamm Bowel Dis，2019，25（1）：97-110.
[18] Battistini C，Ballan R，Herkenhoff M，et al. Vitamin D modulates intestinal microbiota in inflammatory bowel diseases [J]. Int J Mol Sci，2020，22（1）：362.
[19] Lu R，Zhang Y，Xia Y，et al. Paneth cell alertness to pathog- ens maintained by vitamin D receptors [J]. Gastroenterology，2021，160（4）：1269-1283.
[20] Liang S，Cai J，Li Y，et al. 1，25-Dihydroxy-Vitamin D3 induces macrophage polarization to M2 by upregulating T-cell Ig-mucin-3 expression [J]. Mol Med Report，2019， 19（5）：3707-3713.
[21] Vanherwegen A，Eelen G，Ferreira G，et al. Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabo- lism [J]. J Steroid Biochem Mol Biol，2019，187：134-145.
[22] Vernia F，Valvano M，Longo S，et al. Vitamin D in inflammatory bowel diseases. Mechanisms of action and therapeutic implications [J]. Nutrients，2022，14（2）：269.
[23] Quesada-Gomez J，Bouillon R. Is calcifediol better than cholecalciferol for vitamin D supplementation? [J]. Osteoporos Int，2018，29（8）：1697-1711.
[24] Heaney R，Recker R，Grote J，et al. Vitamin D3 is more potent than vitamin D2 in humans [J]. J Clin Endocrinol Metab，2011，96（3）：E447-E452.
[25] Sosa Henríquez M，Gómez De Tejada Romero MJ. Cholecalciferol or calcifediol in the management of vitamin D deficiency [J]. Nutrients，2020，12（6）：1617.
[26] Vaes A，Tieland M，De Regt M，et al. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites：a randomized controlled trial in older adults [J]. Clin Nutr，2018，37（3）：808-814.
[27] Miheller P，Muzes G，Hritz I，et al. Comparison of the effects of 1，25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn’s disease patients [J]. Inflamm Bowel Dis，2009，15（11）：1656-1662.
[28] Mahmoudi L，Asadi S，Al-Mousavi Z，et al. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease [J]. Clin Nutr，2021，40（5）：2999-3005.
[29] Karimi S，Tabataba-Vakili S，Yari Z，et al. The effects of two vitamin D regimens on ulcerative colitis activity index，quality of life and oxidant/anti-oxidant status [J]. Nutr J，2019，18（1）：16.
[30] Myint A，Sauk J，Limketkai B. The role of vitamin D in inflammatory bowel disease：a guide for clinical practice [J]. Expert Rev Gastroenterol Hepatol，2020，14（7）：539-552.
[31] Ross A，Manson J，Abrams S，et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine：what clinicians need to know [J]. J Clin Endocrinol Metab，2011，96（1）：53-58.